Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 34, 2020 - Issue 18
329
Views
13
CrossRef citations to date
0
Altmetric
Short Communications

Xanthatin mediates G2/M cell cycle arrest, autophagy and apoptosis via ROS/XIAP signaling in human colon cancer cells

, , , , , & show all
Pages 2616-2620 | Received 02 Jul 2018, Accepted 29 Oct 2018, Published online: 27 Dec 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Luis Miguel Guamán-Ortiz, Natalia Bailon-Moscoso, Vladimir Morocho, Daisy Vega-Ojeda, Fernando Gordillo & Alírica I. Suárez. (2021) Onoseriolide, from Hedyosmum racemosum, induces cytotoxicity and apoptosis in human colon cancer cells. Natural Product Research 35:18, pages 3151-3155.
Read now
Yuan He, Dongyu Lei, Qingqing Yang, Hao Qi, Kurax Almira, Dilnigar Askar, Lu Jin & Le Pan. (2021) X anthium Orientale subsp. Italicum (Moretti) Greuter: bioassay-guided isolation and its chemical basis of antitumor cytotoxicity. Natural Product Research 35:14, pages 2433-2437.
Read now

Articles from other publishers (11)

Yunxiao Liu, Xinge Zhang, Fenting Cheng, Wei Cao, Yadi Geng, Zhaolin Chen, Wei Wei & Lei Zhang. (2023) Xanthatin induce DDP‐resistance lung cancer cells apoptosis through regulation of GLUT1 mediated ROS accumulation. Drug Development Research.
Crossref
Huaqing Chen, Tong Zhu, Xiaojie Huang, Wenshuang Xu, Zemin Di, Yuyang Ma, Min Xue, Sixing Bi, Yujun Shen, Yongqiang Yu, Yuxian Shen & Lijie Feng. (2022) Xanthatin suppresses proliferation and tumorigenicity of glioma cells through autophagy inhibition via activation of the PI3K‐Akt–mTOR pathway. Pharmacology Research & Perspectives 11:1.
Crossref
Yuanqi Liu, Wenyu Chen, Fang Zheng, Huanan Yu & Kun Wei. (2022) Xanthatin Alleviates LPS-Induced Inflammatory Response in RAW264.7 Macrophages by Inhibiting NF-κB, MAPK and STATs Activation. Molecules 27:14, pages 4603.
Crossref
Yulia Kirdeeva, Olga Fedorova, Alexandra Daks, Nikolai Barlev & Oleg Shuvalov. (2022) How Should the Worldwide Knowledge of Traditional Cancer Healing Be Integrated with Herbs and Mushrooms into Modern Molecular Pharmacology?. Pharmaceuticals 15:7, pages 868.
Crossref
Yanbo Xie, Xueyu Zhu, Ping Liu, Yunxiao Liu, Yadi Geng & Lei Zhang. (2022) Xanthatin inhibits non‐small cell lung cancer proliferation by breaking the redox balance. Drug Development Research.
Crossref
Yadi Geng, Lingli Li, Ping Liu, Zhaolin Chen, Aizong Shen & Lei Zhang. (2022) TMT-Based Quantitative Proteomic Analysis Identified Proteins and Signaling Pathways Involved in the Response to Xanthatin Treatment in Human HT-29 Colon Cancer Cells. Anti-Cancer Agents in Medicinal Chemistry 22:5, pages 887-896.
Crossref
Lingli Li, Ping Liu, Yanbo Xie, Yunxiao Liu, Zhaolin Chen, Yadi Geng & Lei Zhang. (2021) Xanthatin inhibits human colon cancer cells progression via mTOR signaling mediated energy metabolism alteration . Drug Development Research 83:1, pages 119-130.
Crossref
Jian Zhang, Sheng Yang, Hongmei Guan, Jueyu Zhou & Yuan Gao. (2021) Xanthatin synergizes with cisplatin to suppress homologous recombination through JAK2/STAT4/BARD1 axis in human NSCLC cells. Journal of Cellular and Molecular Medicine 25:3, pages 1688-1699.
Crossref
Huailu Tu & Max Costa. (2020) XIAP’s Profile in Human Cancer. Biomolecules 10:11, pages 1493.
Crossref
Shangguan Jian, Liang Chen, Lian Minxue, Che Hongmin, Tang Ronghua, Fan Xiaoxuan, Zhang Binbin & Guo Shiwen. (2020) Tanshinone I induces apoptosis and protective autophagy in human glioblastoma cells via a reactive oxygen species‑dependent pathway. International Journal of Molecular Medicine.
Crossref
Jiquan Wang, Yingbing Zhang, Xu Liu, Jizhao Wang, Bin Li, Yongkang Liu & Jiansheng Wang. (2019) Alantolactone enhances gemcitabine sensitivity of lung cancer cells through the reactive oxygen species-mediated endoplasmic reticulum stress and Akt/GSK3β pathway. International Journal of Molecular Medicine.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.